Potential Coronavirus Treatment Hydroxychloroquine Enters Clinical Trial, NIH Says

A human clinical trial for an antimalarial drug — hydroxychloroquine — believed to be a possible treatment option for patients with COVID-19 infections began this week, according to the National Institute of Health (NIH). The worldwide death toll from the new coronavirus surpassed 101,000 amid about 1.6 million cases and more than 372,000 recoveries, according to the Johns Hopkins University tally.

On Thursday, NIH said in a news release that the clinical trial for the drug…

Read Entire Article Here…

Leave a Reply

Your email address will not be published. Required fields are marked *